Rybelsus for weight loss – semaglutide in tablet form
For people who want to undergo medical weight loss treatment but prefer to avoid weekly injections, Rybelsus offers an alternative in tablet form. The medication contains the active ingredient semaglutide, the same hormone-mimicking compound found in Ozempic and Wegovy.
Because Rybelsus is primarily approved for the treatment of type 2 diabetes but is sometimes prescribed off-label for weight loss, many people have questions about how the treatment works, what results can be expected, and how safe prescribing is managed.
What is Rybelsus?
Rybelsus is a prescription medication containing semaglutide that reduces appetite by mimicking the body's natural GLP-1 hormone. By increasing feelings of fullness, slowing stomach emptying, and reducing sugar cravings and food noise, the tablet supports the lifestyle changes needed for sustainable weight loss. It is taken once daily on an empty stomach and may sometimes be prescribed off-label for weight loss in people with a BMI over 30, or over 27 with weight-related health conditions.
Rybelsus should be taken daily as prescribed and combined with a healthy diet and regular exercise for the best results. The medication should only be used under the guidance of a physician, and the dosage is adjusted individually.
How is Rybelsus administered?
Rybelsus is taken as a daily tablet. It should be taken in the morning after at least eight hours of fasting, together with no more than 120 ml of plain water, to ensure the medication is properly absorbed in the stomach.
Because oral semaglutide has very low natural bioavailability, food, coffee, juice, and other drinks can interfere with the absorption of the active ingredient. After swallowing the tablet whole, patients must wait at least 30 minutes before eating breakfast, drinking anything else, or taking other oral medications.
Treatment begins with a very low daily dose, typically 1.5 mg during the first 30 days, allowing the body time to adapt. The dose may then be gradually increased to 4 mg and later 9 mg if needed, according to the prescribing physician's instructions.
The tablets should always be kept in their original blister packaging until use to protect them from moisture. If a dose is missed, it should be skipped completely, and the next dose should be taken as normal the following day. Patients should never take a double dose to make up for a missed tablet.
At Yazen, physicians follow the principle of the lowest effective dose. This means the dose is not increased if the desired appetite control and weight loss are achieved at a lower dose, helping to minimise unnecessary side effects.
Who can receive Rybelsus?
Rybelsus is officially prescribed to adults with inadequately controlled type 2 diabetes when diet and exercise alone are not enough to manage blood sugar levels.
In some cases, Rybelsus may be prescribed off-label for weight loss in people with a BMI over 30, or a BMI over 27 combined with a weight-related medical condition. However, medications specifically approved and dosed for weight management, such as Wegovy, may be recommended instead.
A prescription for Rybelsus always requires an individual assessment by a licensed physician. The physician will review the patient's medical history, BMI, blood test results, and overall health to ensure that the treatment is safe and appropriate.
Rybelsus should be taken daily according to the physician's instructions and as part of a comprehensive treatment plan that includes a healthy diet and regular physical activity to support sustainable weight loss.
Results: how much weight can you lose with Rybelsus?
Clinical data from the Phase 3 OASIS-1 study showed that participants with overweight or obesity without diabetes achieved an average weight loss of approximately 15% after 68 weeks of treatment with a studied daily dose of 50 mg oral semaglutide.
This result is comparable to the average weight loss of around 15% seen with Wegovy injections over the same period. The biological effects on appetite and satiety are fundamentally similar, provided that the dosing instructions are followed carefully to ensure the medication is absorbed correctly.
However, individual results vary depending on factors such as starting weight, dosage, response to treatment, and how consistently lifestyle changes are followed. Rybelsus is approved for type 2 diabetes rather than obesity, and the 50 mg dose investigated in OASIS-1 is different from the currently prescribed Rybelsus doses.
Side effects that may occur during treatment
The most common side effects of Rybelsus are mild to moderate gastrointestinal symptoms such as nausea, diarrhoea, constipation, and vomiting. These typically occur during the first few weeks of treatment or after a dose increase.
Because semaglutide slows stomach emptying, food remains in the stomach longer than the body is accustomed to, which can initially cause bloating or nausea. By starting with a very low daily dose (1.5 mg) during the first 30 days, the body has time to adapt before the dose is gradually increased to 4 mg and later 9 mg if needed.
Patients can also reduce and prevent gastrointestinal symptoms by following simple dietary and lifestyle advice:
- Eat smaller portions: Stop eating before you feel completely full.
- Avoid fatty and fried foods: Fatty foods remain in the stomach even longer and often worsen nausea.
- Drink enough water every day: Staying well hydrated is essential for preventing constipation as bowel movements slow down and for reducing the risk of dehydration.
To minimise side effects during medical weight loss treatment, Yazen's physicians always follow the principle of the lowest effective dose. This means the dose is not increased if the desired results are achieved at a lower dose.
FAQs:
Can Rybelsus be prescribed for weight loss?
Yes. Licensed physicians may prescribe Rybelsus off-label (outside its approved indication) for weight management if an individual medical assessment shows that the patient meets the eligibility criteria, such as having a BMI of at least 30, or a BMI of at least 27 combined with a weight-related medical condition.
Can you drink alcohol while taking Rybelsus?
Yes, but alcohol should be consumed with caution. Because semaglutide slows stomach emptying, alcohol remains in the gastrointestinal tract for longer, which may significantly increase the risk of side effects such as nausea, heartburn, and acid reflux. In addition, many people experience a lower tolerance to alcohol as they lose weight.
What happens if you forget to take a tablet in the morning?
If you miss your morning dose and have already eaten or had breakfast, you should skip the missed dose completely. Take your next dose as usual the following morning. Never take a double dose to make up for a missed one.
How is Rybelsus different from other semaglutide medications from Novo Nordisk?
The main difference between Rybelsus and other semaglutide medications from Novo Nordisk, such as Ozempic and Wegovy, is the method of administration and dosing frequency. Rybelsus is the first GLP-1 medication available as a tablet and is taken once daily on an empty stomach, while Ozempic and Wegovy are administered as weekly injections. Despite these differences, all three medications contain the same active ingredient, semaglutide, and have similar effects on appetite regulation and weight loss.